- $75.30m
- $75.53m
- $19.21m
Annual income statement for FatPipe, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 12.4 | 15.8 | 17.9 | 16.3 | 19.2 |
| Cost of Revenue | |||||
| Gross Profit | 11.7 | 14.7 | 16.8 | 15.2 | 17.5 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 12.6 | 12.6 | 12.2 | 12.8 | 15.6 |
| Operating Profit | -0.224 | 3.24 | 5.64 | 3.47 | 3.59 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.487 | 3.14 | 5.6 | 3.29 | 3.49 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.454 | 2.89 | 4.28 | 1.95 | 4.97 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.484 | 2.91 | 4.37 | 1.97 | 4.97 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.484 | 2.91 | 4.37 | 1.97 | 4.97 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.037 | 0.212 | 0.318 | 0.143 | 0.355 |
| Dividends per Share |